{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-24T12:23:00.746639+00:00",
  "news": [
    {
      "title": "Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-24T04:57:34+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Teacher Retirement System of Texas Decreases Stake in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNalMwWmFhOU5SbThkRW0tVUI5U3FwUkRiNThJUVJtaEZIdmZDWWxWRGNIT1lWU3ppMnBEQkFSSUxkV1pxak1vU3J3RmVfX3AwR041bTVCLTZGX0hZbHJscXFIaTV4NUdDV0lTVEdKYk5teWwwWndUbEpPUVl2b2s3MHlMekU5WlNHdlNYWW03dXQ3VUpEYktQV3hKRGJwT3NmT0NJTGZtdlpaQ19VaDl2RDFYdUR3eW1mWnVvNnZ5V1hPZDUxMWFJQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNalMwWmFhOU5SbThkRW0tVUI5U3FwUkRiNThJUVJtaEZIdmZDWWxWRGNIT1lWU3ppMnBEQkFSSUxkV1pxak1vU3J3RmVfX3AwR041bTVCLTZGX0hZbHJscXFIaTV4NUdDV0lTVEdKYk5teWwwWndUbEpPUVl2b2s3MHlMekU5WlNHdlNYWW03dXQ3VUpEYktQV3hKRGJwT3NmT0NJTGZtdlpaQ19VaDl2RDFYdUR3eW1mWnVvNnZ5V1hPZDUxMWFJQQ?oc=5\" target=\"_blank\">Teacher Retirement System of Texas Decreases Stake in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-24T12:08:39+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-01-12T23:45:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Dow Jones Stocks: Nvidia, Amgen Are Near Buy Points But This Longtime Loser Is Winning The Week - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPYi1fTG5xX19hdWV6YnJzZzlWaUZfRjVjM2hJWjlMMFJQV2RxdEtnMzRfWFpiQXpPUzJzc0FqZlRISWtETGR5eS1fTG0tYVZmMXVxNGtfNHJmUGdHb3dlNFctX3p3bGEybmUwLXQ0b0dfcUdCanh1Wl9iS3F2Z2hrbGllbzZDUmotNjNzSnNIMG8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPYi1fTG5xX19hdWV6YnJzZzlWaUZfRjVjM2hJWjlMMFJQV2RxdEtnMzRfWFpiQXpPUzJzc0FqZlRISWtETGR5eS1fTG0tYVZmMXVxNGtfNHJmUGdHb3dlNFctX3p3bGEybmUwLXQ0b0dfcUdCanh1Wl9iS3F2Z2hrbGllbzZDUmotNjNzSnNIMG8?oc=5\" target=\"_blank\">Dow Jones Stocks: Nvidia, Amgen Are Near Buy Points But This Longtime Loser Is Winning The Week</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2026-01-23T18:49:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Sagebrush sues Amgen over 340B program row - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5\" target=\"_blank\">Sagebrush sues Amgen over 340B program row</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-01-22T13:25:23+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNQzgtRTN5R0dQenFyLVJvTWhGaDlwMGhjWHpfTGFSNkZ0a1FPM0RnOFJNUFhzMWdheUVkS0VnR3JiaF9fZU1jcHFJeU1XWDFXQWdBSTlSZDYzdWFabW9JemZabFB1S0tUeXVKakZhcnd1R0luOHR4NFJhcHNUNjVWS3VoQlhSN0FQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNQzgtRTN5R0dQenFyLVJvTWhGaDlwMGhjWHpfTGFSNkZ0a1FPM0RnOFJNUFhzMWdheUVkS0VnR3JiaF9fZU1jcHFJeU1XWDFXQWdBSTlSZDYzdWFabW9JemZabFB1S0tUeXVKakZhcnd1R0luOHR4NFJhcHNUNjVWS3VoQlhSN0FQ?oc=5\" target=\"_blank\">Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-21T12:11:01+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRStIB2gFBVV95cUxOV1VkLV9BSGdmbmR6anpGRENtdVctYTJEUUxEdXVCZ25PUV9qbHVNMGoyOFdxSE00TGk3QV9uV3Z2d1hTS0VJaEpmMXNJUzhIZTNjX2JnNHYwN29fQldveUsyWjhQQkR6bDh6dElyZlRDa0dnTDNxN0pNS0xUdVZwdGxaNmZpVVdDNFJ4U1RuZ040dy1wZUJkTXNKbzBIMkZzMlJ2U1c1TEloTmtFUGx3ZERfcGFQQURKUDNWcFdWVzJYQzM5dExHc2ZNQ2czcFU5c1pwOUxoV0NFQQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "AMGEN INC SEC 10-Q Report - TradingView — Track All Markets",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5\" target=\"_blank\">AMGEN INC SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView — Track All Markets</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView — Track All Markets"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-23",
      "close": 344.75
    },
    "history": [
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      },
      {
        "date": "2026-01-15",
        "close": 330.0299987792969
      },
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      },
      {
        "date": "2026-01-20",
        "close": 331.0
      },
      {
        "date": "2026-01-21",
        "close": 343.6000061035156
      },
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      },
      {
        "date": "2026-01-23",
        "close": 344.75
      }
    ],
    "name": "Amgen Inc."
  }
}